Quality Assurance

We actively maintain rigorous in-house and external quality assurance schemes, ensuring that Micropathology Ltd continues to meet the necessary regulatory standards (ISO 15189:2012).

We took part in the following external quality assurance schemes (2021):

United Kingdom National External Quality Assessment ServiceUnited Kingdom National External Quality Assessment Service

  • Anti-HBsAg
  • Blood-Borne Virus donor screen (serology for hepatitis C Ag and AB, hepatitis B (HBVSAg, Anti-HBV Core), HIV 1 and 2 Ag and AB (including p24), HTLV 1 and 2 AB
  • Fungal biomarkers
  • HepB serology (Surface antigen, 'e' antigen, 'e' antibody, core antibody)
  • HFE (Haemachromatosis) H63D, C282Y & S65C mutations
  • Thrombophilia gene mutations (Factor V Leiden & Prothrombin)
  • Measles & mumps IgG
  • Molecular tissue identification (GenQA)
  • Mycobacteria (molecular)
  • Mycology (Molecular fungal identification)

Quality Control for Molecular DiagnosticsQuality Control for Molecular Diagnostics

  • HIV-1 DNA/RNA detection
  • HSV drug resistance
  • Aspergillus spp.
  • Bacterial 16S panel
  • Bacterial sepsis (Staphylococcus, Serratia, Escherichia coli, Staphylococcus, Enterococcus, Streptococcus and Klebsiella, Pseudomonas)
  • Bordetella pertussis
  • Borrelia burgdorferi
  • Candida spp.
  • Central nervous system II (Listeria spp., Neisseria meningitides, Streptococcus pneumoniae, Streptococcus agalactiae, Escherichia coli, Aspergillus spp., Haemophilus influenzae strains, tococcus neoformans)
  • Chlamydia pneumoniae
  • Chlamydia psittacii
  • Chlamydia trachomatis
  • Group B Streptococcus
  • Mycobacterium tuberculosis
  • Mycoplasmoides genitalium including macrolide and fluoroquinolone resistance
  • Mycoplasmoides pneumoniae
  • Mycoplasma sp.
  • Neisseria gonorrhoeae
  • Non-tuberculosis Mycobacteria spp.
  • Pneumocystis jirovecii
  • STI screen (Mycoplasmoides genitalium, Ureaplasma sp, Trichomonas vaginalis, Gardnerella vaginalis)
  • Respiratory III (Pertussis, Legionella pneumoniae, Mycoplasmoides pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae strains)
  • Toxoplasma gondii
  • Treponema pallidum

INSTAND panels

  • Adenovirus DNA quantitation
  • CMV DNA quantitation
  • CMV drug resistance (UL97/UL54/)
  • EBV DNA quantitation
  • Enterovirus RNA
  • HBV DNA quantitation
  • HBV drug resistance
  • HBV genotyping
  • HCV drug resistance
  • HCV genotyping
  • HCV RNA quantitation
  • HDV RNA quantitation
  • HEV RNA quantitation
  • HHV6 DNA quantitation
  • HHV-8 DNA detection
  • HIV-1 drug resistance (protease/reverse transcriptase / integrase)
  • HIV-1 RNA quantitation
  • HIV-2 RNA detection
  • HPV DNA detection
  • HSV DNA detection and typing
  • influenza virus A and B RNA detection
  • measles RNA detection
  • mumps RNA detection
  • parechovirus RNA detection
  • parvovirus B19 DNA quantitation
  • polyoma virus BK DNA quantitation
  • polyoma virus JC
  • Respiratory II (MPV, Adenovirus, Rhinovirus, coronavirus, enterovirus, parainfluenza viruses 1-4).
  • RSV RNA detection
  • Rubella RNA
  • SARS-CoV-2 RNA detection
  • VZV DNA detection
  • West Nile virus RNA detection
  • Coxiella burnetii DNA
  • Brucella sp. DNA

Veterinary laboratory agency

  • Leptospira genus

English Speaking Working Group (of the International Society for Forensic Genetics)

  • Human relationship testing proficiency scheme

Informal interlaboratory exchange schemes 2019 included:

  • Bartonella sp.
  • Tropheryma whipplei
  • Group A Streptococcus – Streptococcus pyogenes
  • Propionibacterium acnes

If you have any questions about our quality management system please contact our Quality Manager, Dr Andrea Collins.

You may want to download our Quality Manual.